» Articles » PMID: 29998127

Inherited Cardiomyopathies and the Role of Mutations in Non-coding Regions of the Genome

Overview
Date 2018 Jul 13
PMID 29998127
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiomyopathies (CMs) are a group of cardiac pathologies caused by an intrinsic defect within the myocardium. The relative contribution of genetic mutations in the pathogenesis of certain CMs, such as hypertrophic cardiomyopathy (HCM), arrythmogenic right/left ventricular cardiomyopathy (ARVC) and left ventricular non-compacted cardiomyopathy (LVNC) has been established in comparison to dilated cardiomyopathy (DCM) and restrictive cardiomyopathy (RCM). The aim of this article is to review mutations in the non-coding parts of the genome, namely, microRNA, promoter elements, enhancer/silencer elements, 3'/5'UTRs and introns, that are involved in the pathogenesis CMs. Additionally, we will explore the role of some long non-coding RNAs in the pathogenesis of CMs.

Citing Articles

Recent Clinical Updates of Hypertrophic Cardiomyopathy and Future Therapeutic Strategies.

Zhao M, He X, Min X, Yang H, Wu W, Zhong J Rev Cardiovasc Med. 2025; 26(2):25132.

PMID: 40026515 PMC: 11868910. DOI: 10.31083/RCM25132.


Technologies for Targeted RNA Degradation and Induced RNA Decay.

Mikutis S, Bernardes G Chem Rev. 2024; 124(23):13301-13330.

PMID: 39499674 PMC: 11638902. DOI: 10.1021/acs.chemrev.4c00472.


Cardiomyopathy: pathogenesis and therapeutic interventions.

Huang S, Li J, Li Q, Wang Q, Zhou X, Chen J MedComm (2020). 2024; 5(11):e772.

PMID: 39465141 PMC: 11502724. DOI: 10.1002/mco2.772.


The role of noncoding genetic variants in cardiomyopathy.

Htet M, Lei S, Bajpayi S, Zoitou A, Chamakioti M, Tampakakis E Front Cardiovasc Med. 2023; 10:1116925.

PMID: 37283586 PMC: 10239966. DOI: 10.3389/fcvm.2023.1116925.


Role of non-coding variants in cardiovascular disease.

Heshmatzad K, Naderi N, Maleki M, Abbasi S, Ghasemi S, Ashrafi N J Cell Mol Med. 2023; 27(12):1621-1636.

PMID: 37183561 PMC: 10273088. DOI: 10.1111/jcmm.17762.


References
1.
Muslin A, Tanner J, Allen P, Shaw A . Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell. 1996; 84(6):889-97. DOI: 10.1016/s0092-8674(00)81067-3. View

2.
Ramasawmy R, Cunha-Neto E, Fae K, Martello F, Muller N, Cavalcanti V . The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin Infect Dis. 2006; 43(3):305-11. DOI: 10.1086/505395. View

3.
Krajinovic M, Elbared J, Drouin S, Bertout L, Rezgui A, Ansari M . Polymorphisms of ABCC5 and NOS3 genes influence doxorubicin cardiotoxicity in survivors of childhood acute lymphoblastic leukemia. Pharmacogenomics J. 2015; 16(6):530-535. DOI: 10.1038/tpj.2015.63. View

4.
Perkel J . Visiting "noncodarnia". Biotechniques. 2013; 54(6):301, 303-4. DOI: 10.2144/000114037. View

5.
Maron B, Towbin J, Thiene G, Antzelevitch C, Corrado D, Arnett D . Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and.... Circulation. 2006; 113(14):1807-16. DOI: 10.1161/CIRCULATIONAHA.106.174287. View